MedPath

Isthmus Ablation With Gold Electrode for Treatment of Atrial Flutter (AURUM 8)

Phase 4
Completed
Conditions
Atrial Flutter
Interventions
Device: Gold tip catheter
Device: Platinum-iridium tip catheter
Registration Number
NCT00326001
Lead Sponsor
Biotronik SE & Co. KG
Brief Summary

The purpose of this study is to demonstrate the advantage of using a gold alloy tip electrode over a platinum/iridium alloy tip electrode in ablation of the cavotricuspid isthmus in patients with atrial flutter.

Detailed Description

Transvenous catheter ablation has become the therapy of choice for patients with recurring, isthmus-dependent right atrial flutter. Achieving bidirectional conduction block in the cavotricuspid isthmus is decisive for both acute and long-term therapy success and essentially depends on the selected ablation method and the lesion size. By using an 8 mm tip electrode instead of a conventional 4 mm electrode, deeper lesions can be made, thus significantly reducing the required number of energy applications for achieving a bidirectional conduction block. Experimental studies have proven that using an ablation electrode made of gold alloy allows the creation of deeper lesions than with conventional platinum-iridium electrodes. Due to the greater heat conductivity of the gold alloy as opposed to platinum-iridium, the cooling of the ablation electrode is improved and more electric energy can be transmitted to the tissue at identical temperatures.

The combination of both technologies in the form of an 8 mm-long gold electrode anticipates that the lesion depth required for an isthmus block can be achieved more quickly in comparison to the platinum-iridium electrode.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
463
Inclusion Criteria
  • At least one electrocardiogram (ECG)-documented (can be older than 3 months), symptomatic, typical atrial flutter episode with either negative, sawtooth-shaped P-waves in leads II, III, and augmented voltage foot (aVF), or positive P-waves in leads II, III, and aVF
  • At least one persistent, typical atrial flutter episode of over 2 hours that has been documented in the history in the patient file and/or ECG
  • Signed informed consent form
Exclusion Criteria
  • Patient has recently undergone isthmus ablation
  • Acute coronary syndrome or myocardial infarction within the last 3 months
  • Acute reversible causes for atrial flutter (e.g. acute myocarditis)
  • Severe cardiac valvular defects
  • Tricuspid valve replacement
  • Atrial septum defect
  • Cardiovascular surgery scheduled within the next 6 months
  • Unstable medication in the last 7 days before study inclusion
  • New York Heart Association (NYHA) class IV
  • Women who are breastfeeding
  • Pregnancy
  • Abuse of drugs or alcohol
  • Patient is unable to participate in follow-up examinations
  • The patient has only partial legal competence
  • Participation in another clinical study
  • The ablation procedure presents an above average risk to the patient as compared to the normal patient group (must be noted by the physician on the appropriate form).
  • Right atrial thrombus

Late Exclusion Criteria:

  • Patient included by accident
  • Premature termination of the ablation procedure
  • Atrial flutter not dependent on the posterior isthmus
  • No conduction at the posterior isthmus before ablation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Gold tip catheterGold tip catheterGold tip catheter
Platinum-iridium tip catheterPlatinum-iridium tip catheterPlatinum-iridium tip catheter
Primary Outcome Measures
NameTimeMethod
Duration of Energy Applicationablation procedure

Cumulative amount of time current is flowing through the catheter tip. The current (in the radiofrequency range) is applied to ablate the cavotricuspid isthmus in the right atrium.

Secondary Outcome Measures
NameTimeMethod
Ablation Success With the First Catheterablation procedure

Delivery of radiofrequency current was repeated until a cavotricuspid isthmus (CTI) conduction block was detected. The final bidirectional CTI block test (well documented in the literature) was performed 20 minutes after the last radiofrequency current delivery to assess ablation success (Y/N).

Positive final bidirectional cavotricuspid isthmus condution block test means "ablation successful".

Negative final bidirectional cavotricuspid isthmus condution block test means "ablation unsuccessful"; ablation should be continued until success or terminated and classified as unsuccess.

Number of Patients With Long-term Treatment Success6 months after ablation

No recurrence of atrial flutter after ablation

Number of Patients With Charred Catheter Tipsablation procedure

Char or coagulum formation on the catheter tip

Trial Locations

Locations (28)

Charité Campus Mitte, Medizinische Fakultät der Humboldt Universität zu Berlin

🇩🇪

Berlin, Germany

The University of Pecs

🇭🇺

Pecs, Hungary

Evangelisches Krankenhaus Düsseldorf

🇩🇪

Duesseldorf, Germany

Universitätsklinikum Charité, Campus Benjamin Franklin

🇩🇪

Berlin, Germany

Universitätsklinikum Charité, Campus Buch Franz-Volhard-Klinik

🇩🇪

Berlin, Germany

Medizinische Einrichtungen der Rheinischen Friedrich-Wilhelms-Universität Bonn

🇩🇪

Bonn, Germany

Universitätskliniken des Saarlandes

🇩🇪

Homburg/Saar, Germany

Kerckhoff Klinik

🇩🇪

Bad Nauheim, Germany

Vivantes Klinikum Am Urban

🇩🇪

Berlin, Germany

Berufsgenossenschaftliche Kliniken, Bergmannsheil Universitätsklinik

🇩🇪

Bochum, Germany

Städtisches Krankenhaus München-Bogenhausen

🇩🇪

München, Germany

Institute of Clinical and Experimental Medicine

🇨🇿

Praha, Czech Republic

Georg-August-Universität, Universitätsklinikum Göttingen

🇩🇪

Goettingen, Germany

Elektrophysiologische Praxis am Zentralkrankenhaus Links Der Weser

🇩🇪

Bremen, Germany

Universitätsklinikum Charité, Campus Virchow-Klinikum

🇩🇪

Berlin, Germany

Herzzentrum Duisburg

🇩🇪

Duisburg, Germany

Allgemeines Krankenhaus Altona

🇩🇪

Hamburg, Germany

Medizinische Hochschule Hannover

🇩🇪

Hannover, Germany

Universitätsklinik der RWTH Aachen

🇩🇪

Aachen, Germany

Universitätsklinikum Hamburg-Eppendorf

🇩🇪

Hamburg, Germany

St. Vincentius Krankenhaus/St. Marien Krankenhaus - Abteilung für Innere Medizin III

🇩🇪

Karlsruhe, Germany

Herzzentrum Leipzig GmbH

🇩🇪

Leipzig, Germany

Universitätsklinikum Mainz

🇩🇪

Mainz, Germany

Semmelweis Medical University - Department of Cardiology

🇭🇺

Budapest, Hungary

Klinikum der Stadt Villingen-Schwenningen GmbH

🇩🇪

Villingen-Schwenningen, Germany

Medizinische Universitätsklinik Würzburg

🇩🇪

Würzburg, Germany

The Debrecen University of Medicine, Center of Medicine and Health Care Sciences, Clinical Department of Cardiology

🇭🇺

Debrecen, Hungary

Universitätsklinikum Ulm

🇩🇪

Ulm, Germany

© Copyright 2025. All Rights Reserved by MedPath